SANUWAVE Health Stock
SANUWAVE Health Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Morgan C. Frank
- Employees
- 55
- Market cap
- $43 M
- IPO
- 18/10/2024
- Web
- sanuwave.com
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new…
SANUWAVE Health stock: price history
1D
-4.1%
1W
-11.7%
1M
+17.5%
6M
-75.9%
YTD
-83.4%
1Y
-85.8%
2Y
-64.5%
5Y
-89.0%
10Y
-93.2%
Next earnings date
Next earnings date
06/11/2026 (in 20 days)
Volatility around earnings
~11% stronger price swings than usual
Ask the agents about SANUWAVE Health
Analyst assessment of SANUWAVE Health
PRICE TARGET LOW
US$53.00
CONSENSUS
US$54.00
MEDIAN
US$54.00
PRICE TARGET HIGH
US$55.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 30/03/2026
SANUWAVE Health stock metrics
P/E
2.97
P/B
15.31
EV/EBITDA
2.75
RETURN ON EQUITY
-24.5%
NET MARGIN
-7.0%
DEBT/EQUITY
7.43
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.6%
FLOAT SHARES
8,136,168
AVG. DAILY VOLUME (30D)
57,635
Insider transactions (SEC)
Opaleye Management Inc.
Opaleye Management Inc.
Opaleye Management Inc.
Opaleye Management Inc.
Opaleye Management Inc.
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about SANUWAVE Health stock
What does SANUWAVE Health do?
SANUWAVE Health Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Morgan C. Frank, the company employs around 55 people.
The IPO was on 18/10/2024; the stock trades on NASDAQ under the ticker SNWV.
What do analysts say about SANUWAVE Health stock?
2 analysts rate the stock, the consensus is Buy (as of 30/03/2026).
The average price target is US$54.00, ranging from US$53.00 to US$55.00, with a median of US$54.00.
This is an external assessment, not a statement by Market Jury.
When does SANUWAVE Health report next?
The next earnings date is 06/11/2026.
Around past earnings, price swings were roughly 11% stronger than usual.
Does SANUWAVE Health pay a dividend?
No, SANUWAVE Health currently does not pay a dividend.
Which stocks are comparable to SANUWAVE Health?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get SANUWAVE Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess SANUWAVE Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.